*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Elbasvir API</strong> is a direct-acting antiviral agent used in pharmaceutical R&D for hepatitis C virus (HCV) treatment. Synthesized via advanced organic processes, it functions as an NS5A replication complex inhibitor. Molecular formula: <strong>C28H29F3N6O4S</strong>; CAS No.: <strong>1370706-65-8</strong>.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical research for HCV genotype 1-4 studies.</li>
<li>Formulation development of fixed-dose combinations with Grazoprevir.</li>
<li>Quality control and analytical method validation in drug discovery.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly for laboratory use only; not approved for clinical administration. Store under inert atmosphere at -20°C. Handle with appropriate PPE to avoid inhalation or skin contact due to potential toxicity.</p>